The Gen XY Lifestyle
Clinical trial shows suppression of dengue fever symptoms by food product
A joint clinical trial found that 2 months of Lactococcus lactis strain Plasma intake reduces the cumulative number of days participants suffer from the main symptoms of dengue fever
A joint clinical trial by Kirin Holdings, the Kirin Central Research Institute at Kirin Holdings and the Tropical Infectious Diseases Research and Education Center (TIDREC) at the University of Malaya found that participants that took Lactococcus lactis strain Plasma (LC-Plasma) for two months significantly reduced the cumulative number of days of fever, muscle pain, joint pain, and pain behind the eyes.
These symptoms are commonly associated as ‘main’ symptoms of dengue fever.
There is no known cure or vaccine for dengue fever. Instead, patients have to rely on coping therapy with the main therapeutic intervention being that of fluid management.
According to Tan Tock Seng Hospital, the main treatments for dengue revolve around fluid and electrolyte replacement, symptom relief and fever control as well as bleeding prevention and control.
These clinical trial results suggest that LC-Plasma can help alleviate the symptoms and prevent the severity of the disease.
LC-Plasma is a food product and a functional ingredient in Kirin Holdings’ stable of IMMUSE material.
According to Kirin Holdings, “LC-Plasma activates the command center of antiviral immunity (and) has been shown to contribute to the prevention of a wide range of viral infections other than the dengue fever virus.”
Feature picture by Welcome to all and thank you for your visit ! ツ from Pixabay
